Smart Money · Holder IQ
65.7 / 100
Above median holder quality (percentile 83.6 this quarter).
CURX
Curanex Pharmaceuticals Inc Common StockNASDAQ
$5.67+0.18%
Close Nov 12, 2026
Reading stored signals…
Healthcare • Biotechnology
- Market cap
- $8.04M
- 1 month
- +14.3%
- 3 months
- +28.7%
- 1 year
- -53.1%
More market facts
- Dividend
- No dividends on record
- Short interest
- 1.2% of float5.9K shares · settled Oct 30, 2026 · +14.4% since Oct 15, 2026 · FINRA
Fundamentals · trailing 12 months to Jun 30, 2026
- Revenue
- —
- Net income
- -$10.47M
- Free cash flow
- -$12.08M
- Book value
- $4.79M
- Total debt
- $276.36K
- P/E
- —
- Price / sales
- —
- Price / book
- 1.7×
- FCF yield
- -150.2%
- Net margin
- —
Trailing twelve-month statements · as of Nov 12, 2026
End-of-day close from stored market data, not a live quote.
About Curanex Pharmaceuticals Inc Common Stock
Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients with inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout. The company was formerly known as Fordman Pharma Inc.
Read more
and changed its name to Curanex Pharmaceuticals Inc in November 2023. Curanex Pharmaceuticals Inc was founded in 1996 and is headquartered in Jericho, New York.
- Website
- curanexpharma.com
- Headquarters
- Jericho, NY, United States
- Employees
- 6
- Listed
- Aug 26, 2025
- Fiscal year ends
- December
Company profile stored Nov 2, 2026.
Quarterly results
The last 8 fiscal quarters from the latest stored normalized financial statements. These may include restatements. Year over year compares the same quarter a year earlier.
| Quarter | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Jun 2026filed Aug 14, 2026 | — | — | — | -$3.3M | -$3.3M |
| Mar 2026filed May 14, 2026 | — | — | — | -$3.2M | -$3.2M |
| Dec 2025filed Mar 30, 2026 | — | — | — | -$3.1M | -$3.1M |
| Sep 2025filed Nov 17, 2025 | — | — | — | -$951.3K | -$954.1K |
| Jun 2025filed Sep 9, 2025 | — | — | — | -$57.7K | -$60.3K |
| Mar 2025filed Mar 31, 2025 | — | — | — | -$137.5K | -$137.6K |
| Dec 2024filed Dec 31, 2024 | — | — | — | -$138.6K | -$137.2K |
| Sep 2024filed Sep 30, 2024 | — | — | — | -$102.1K | -$99.9K |
Balance sheet · cash, debt and near-term obligations
What resources sit beside the obligations? These are balances at each fiscal quarter end, not cash earned during the quarter. Amounts are in USD, the reporting currency.
As of
- Reported cash
- $2.9M
- Reported total debt
- $276.4K
- Current assets
- $4.8M
- Current liabilities
- $104.3K
Vendor filing date:
As of
- Reported cash
- $4.0M
- Reported total debt
- $311.0K
- Current assets
- $8.1M
- Current liabilities
- $128.7K
Vendor filing date:
As of
- Reported cash
- $5.0M
- Reported total debt
- $346.7K
- Current assets
- $11.2M
- Current liabilities
- $137.0K
Vendor filing date:
As of
- Reported cash
- $5.8M
- Reported total debt
- $61.2K
- Current assets
- $14.4M
- Current liabilities
- $186.0K
Vendor filing date:
Link an account to see your stake, watchlist and past holdings. Compare cash and debt across dates when reviewing its reliance on financing. Current assets can include receivables and inventory; current liabilities include bills as well as borrowings. They are not all spendable cash or all debt. These figures alone do not establish the ability to repay.
Source: the latest stored normalized balance sheets, matched to the same security and fiscal end as these income periods. They may include restatements and are not an originally-filed or knowledge-time history. No net debt, coverage ratio or replacement balance is calculated. Read the SEC guide to financial statements for the distinction between balances and cash flows.
Fiscal years · last 4
| Fiscal year | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Dec 2025filed Mar 30, 2026 | — | — | — | -$4.2M | -$4.2M |
| Dec 2024filed Dec 31, 2024 | — | — | — | -$365.1K | -$361.5K |
| Dec 2023filed Dec 31, 2023 | — | — | — | -$19.3K | -$19.2K |
| Dec 2022filed Dec 31, 2022 | $26.0K | — | 17.0% | -$20.2K | -$20.2K |
Annual cash generation
Does profit turn into cash? Compare CURX’s accounting profit with operating cash flow and capital spending. Amounts are in USD.
Fiscal year ending
- Net income
- -$4.2M
- Operating cash flow
- -$10.5M
- Capital spending
- $0.0
- Free cash flow
- -$10.5M
Fiscal year ending
- Net income
- -$361.5K
- Operating cash flow
- -$555.6K
- Capital spending
- $5.0
Fiscal year ending
- Net income
- -$19.2K
- Operating cash flow
- -$120.0
- Capital spending
- $0.0
- Free cash flow
- -$120.0
Link an account to see your stake, watchlist and past holdings. Compare cash generation and investment needs with your thesis. Working capital and non-cash charges can separate profit from cash. Capital spending can reduce free cash flow while earnings rise. For a long or short position, that gap alone does not predict a price move.
Cash-flow source and meaning
Source: Annual financial statements, latest stored vendor-normalized figures. These may include restatements and may differ from the filer’s own XBRL. A filing date is not the knowledge date of this version of the values.
Free cash flow is the vendor’s reported figure, shown only when it agrees with operating cash flow less capital spending recorded as a positive outflow. It is not cash guaranteed for dividends or buybacks, and it does not subtract every financing obligation. Missing or sign-incompatible inputs are not filled in. An unlabelled currency is used only for a confirmed domestic USD filer. These are annual statements, not forecasts or an originally-filed history.
Cash allocation: dividends, shares and debt
Where did CURX’s financing cash go? Compare cash paid as dividends with net share and debt transactions across fiscal years. Amounts are in USD, the reporting currency. These are company-wide totals, not per-share payouts.
Fiscal year ended
Vendor filing date:
- Total financing cash flow
- $15.3M
Fiscal year ended
Vendor filing date:
- Total financing cash flow
- $630.1K
Fiscal year ended
Vendor filing date:
- Total financing cash flow
- $72.1K
Link an account to see your stake, watchlist and past holdings. Compare these uses of cash with operating cash generation and the debt on the balance sheet. A negative net share movement means purchases exceeded issuance; it does not give gross buybacks. A dividend or share purchase can be financed with borrowing, and none of these flows guarantees a future payment or price return.
Allocation source and sign conventions
Source: Annual cash-flow statements, latest stored vendor-normalized values for the same security and fiscal year. These can include restatements; a filing date is not the knowledge date of this version.
Dividends are positive cash paid out. For net share transactions, net borrowing and total financing, positive means cash in and negative means cash out. Net share transactions combine issuance and purchases; they are not gross repurchases, a change in shares outstanding, or stock compensation. Total financing includes other flows and is not the sum of just these three lines. Zero means a reported zero. No FX conversion, shareholder-return total or forecast is inferred.
Short-interest history
Reported short positions, stored float percentages and adjusted prices over the same period.
Shares short
Share of float
Adjusted close · USD
Settlement records · 29 observations
Settlement Oct 30, 2026
5,945 shares short
+750 shares (+14.4%) vs Oct 15, 2026
1.2% of the stored float. Published Nov 10, 2026.
Settlement Oct 15, 2026
5,195 shares short
+2,111 shares (+68.5%) vs Sep 30, 2026
1% of the stored float. Published Oct 26, 2026.
Settlement Sep 30, 2026
3,084 shares short
+261 shares (+9.2%) vs Sep 15, 2026
0.6% of the stored float. Published Oct 9, 2026.
Settlement Sep 15, 2026
2,823 shares short
+2,374 shares (+528.7%) vs Aug 31, 2026
Published Sep 24, 2026.
Settlement Aug 31, 2026
449 shares short
Published Sep 10, 2026.
Settlement Aug 14, 2026
24,375 shares short
+11,986 shares (+96.7%) vs Jul 31, 2026
Published Aug 25, 2026.
Settlement Jul 31, 2026
12,389 shares short
+560 shares (+4.7%) vs Jul 15, 2026
Published Aug 11, 2026.
Settlement Jul 15, 2026
11,829 shares short
-9,006 shares (-43.2%) vs Jun 30, 2026
Published Jul 24, 2026.
Settlement Jun 30, 2026
20,835 shares short
-12,775 shares (-38%) vs Jun 15, 2026
Published Jul 10, 2026.
Settlement Jun 15, 2026
33,610 shares short
+8,171 shares (+32.1%) vs May 29, 2026
Published Jun 25, 2026.
Settlement May 29, 2026
25,439 shares short
-11,812 shares (-31.7%) vs May 15, 2026
Published Jun 9, 2026.
Settlement May 15, 2026
37,251 shares short
-10,407 shares (-21.8%) vs Apr 30, 2026
Published May 27, 2026.
Settlement Apr 30, 2026
47,658 shares short
-3,317 shares (-6.5%) vs Apr 15, 2026
Published May 11, 2026.
Settlement Apr 15, 2026
50,975 shares short
-56,179 shares (-52.4%) vs Mar 31, 2026
Published Apr 24, 2026.
Settlement Mar 31, 2026
107,154 shares short
-311,744 shares (-74.4%) vs Mar 13, 2026
Published Apr 10, 2026.
Settlement Mar 13, 2026
418,898 shares short
-3,339,851 shares (-88.9%) vs Feb 27, 2026
Published Mar 24, 2026.
Settlement Feb 27, 2026
3,758,749 shares short
+3,713,179 shares (+8,148.3%) vs Feb 13, 2026
Published Mar 10, 2026.
Settlement Feb 13, 2026
45,570 shares short
-23,824 shares (-34.3%) vs Jan 30, 2026
Published Feb 25, 2026.
Settlement Jan 30, 2026
69,394 shares short
+8,501 shares (+14%) vs Jan 15, 2026
Published Feb 10, 2026.
Settlement Jan 15, 2026
60,893 shares short
+5,485 shares (+9.9%) vs Dec 31, 2025
Published Jan 27, 2026.
Settlement Dec 31, 2025
55,408 shares short
-14,101 shares (-20.3%) vs Dec 15, 2025
Published Jan 12, 2026.
Settlement Dec 15, 2025
69,509 shares short
-12,035 shares (-14.8%) vs Nov 28, 2025
Published Dec 24, 2025.
Settlement Nov 28, 2025
81,544 shares short
-100,523 shares (-55.2%) vs Nov 14, 2025
Published Dec 9, 2025.
Settlement Nov 14, 2025
182,067 shares short
-26,458 shares (-12.7%) vs Oct 31, 2025
Published Nov 25, 2025.
Settlement Oct 31, 2025
208,525 shares short
+107,680 shares (+106.8%) vs Oct 15, 2025
Published Nov 11, 2025.
Settlement Oct 15, 2025
100,845 shares short
-36,445 shares (-26.5%) vs Sep 30, 2025
Published Oct 24, 2025.
Settlement Sep 30, 2025
137,290 shares short
+67,286 shares (+96.1%) vs Sep 15, 2025
Published Oct 9, 2025.
Settlement Sep 15, 2025
70,004 shares short
-45,460 shares (-39.4%) vs Aug 29, 2025
Published Sep 24, 2025.
Settlement Aug 29, 2025
115,464 shares short
Published Sep 10, 2025.
Change = this settlement’s shares short − the previous recorded settlement’s shares short; percentage change divides by that earlier count. A zero earlier count has no percentage change. Split-spanning counts are left uncompared. Float percentages use the stored settlement observation, not today’s float.
Source: stored FINRA equity short-interest records. Adjusted prices exclude a reused ticker’s earlier issuer. FINRA data and reporting dates · How to read short interest
Dividends and stock splits
Through Nov 13, 2026
Recorded amounts and dates, not confirmation of cash received.
View all 1 split
| Ex-date | Event | Recorded detail |
|---|---|---|
| Aug 20, 2026 | Reverse split | 1 for 20Each 20 pre-split shares become 1 post-split share. |
Cash bars retain the event's recorded currency and share basis. The yield line divides recorded cash in the preceding 365 days, adjusted for intervening splits, by a verified raw close in the same currency. Special dividends are included. Future ex-dates are excluded from yield. A split changes share count, not investment value. For long shares, past entitlement depends on when you held them; short shares can create a dividend payment obligation.
Source: recorded cash-dividend and split events.
Portfolio context
Link an account to see your stake, watchlist and past holdings.
We’ll show you if CURX is in your portfolio and how much it contributes.
Sign inMarket context
Smart money context
Holder IQ: MEDIUM
3 smart-money holders: institutions with a high Holder IQ
Q2 2026, filed Sep 2, 2026
Red flags
Red flags: 0
Largest 13-F holders · Q2 2026
11 filers reported a long position in CURX for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
The top 10 hold
99.7%
of the 334.1K shares 13-F filers reported
Moves vs Q1 2026
2 added3 trimmed
5 new
Net shares held
-18.1%
across the 5 holders with a comparable Q1 2026 book
| Rank | Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|---|
| 1 | Citadel Advisors LLC | $25.3K · 95.3K shares | 95.3K | +88.4% |
| 2 | Virtu Financial LLC | $14K · 51.2K shares | 51.2K | New |
| 3 | Renaissance Technologies LLC | $13.8K · 52K shares | 52K | New |
| 4 | Geode Capital Management, LLC | $10.2K · 38.3K shares | 38.3K | -65.5% |
| 5 | Jane Street Group, LLC | $8.3K · 31.2K shares | 31.2K | New |
| 6 | Two Sigma Investments, LP | $7.3K · 27.4K shares | 27.4K | +35.1% |
| 7 | Susquehanna International Group, LLP | $3.9K · 14.7K shares | 14.7K | New |
| 8 | Ground Swell Capital, LLC | $3.4K · 12.6K shares | 12.6K | New |
| 9 | Citigroup Inc | $2.4K · 9K shares | 9K | -53.7% |
| 10 | UBS Group AG | $400 · 1.5K shares | 1.5K | -81.2% |
Sign in to see each holder’s Holder IQ, factor-adjusted Holder IQ and rank, and compare these holders with all scored filers. Available on every plan.
Sign inMoves the factor model did not explain
How much of CURX’s move accompanied the market and its measured style leanings, and how much was left? The residual is unexplained by this fitted model. It does not establish a cause, skill or future alpha.
Return split unavailable. A complete, reconciled model for every market session in this window is unavailable. Missing dates are not filled.
Link an account with dated transactions to see what share of your own holding’s move since its purchase-date close was unexplained, with long and short positions distinguished. Your private holdings never enter this public chart.
Dated model observations (20)
Daily percentage returns, not window contributions. Source: the same dated warehouse rows and model v1.2.0; observed 2026-11-13T15:35:44.790Z. Absent sessions are never interpolated; missing or failed inputs stay unavailable.
| Date | Stock | Market | Styles | Residual |
|---|---|---|---|---|
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable |
How this split is calculated
Each day uses that day’s fitted market intercept and style exposures multiplied by that day’s published factor returns. Their sum plus the independently stored residual must reconcile to the stock return. Window effects are weighted by stock wealth at each day’s start and added; the stock return compounds. Every expected US market session must be present and pass source, identity, model and numerical checks. This retrospective fit is an explanation of measured returns, not evidence of causation or an investable forecast. The window ends at the latest published model session, which can lag the market; today’s unfinished session is excluded.
What insiders reported owning
Reading dated filing evidence…
Get the Full Analysis for CURX
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.